Global Vocal Biomarkers Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Indication;

Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, and Others

By Composition;

Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, and Others

By Type;

Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, and Others

By End User;

Hospitals & Clinics, Research Institutes, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn730944840 Published Date: May, 2025 Updated Date: June, 2025

Vocal Biomarkers Market Overview

Vocal Biomarkers Market (USD Million)

Vocal Biomarkers Market was valued at USD 2,495.65 million in the year 2024. The size of this market is expected to increase to USD 6,590.15 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 14.9%.


Global Vocal Biomarkers Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 14.9 %


Study Period2025 - 2031
Base Year2024
CAGR (%)14.9 %
Market Size (2024)USD 2,495.65 Million
Market Size (2031)USD 6,590.15 Million
Market ConcentrationLow
Report Pages372
2,495.65
2024
6,590.15
2031

Major Players

  • IBM Corporation
  • Audio Profiling
  • Cogito Corporation
  • Sonde Health
  • Beyond Verbal
  • Boston Technology Corporation
  • Microtest Health

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Vocal Biomarkers Market

Fragmented - Highly competitive market without dominant players


The vocal biomarkers market is steadily expanding, driven by a surge in demand for non-invasive, real-time diagnostic tools. Vocal biomarkers, extracted from speech attributes, are being leveraged across healthcare for conditions ranging from neurological disorders to respiratory diseases. As remote care models gain traction, nearly 30% of health-tech platforms are embedding voice analytics into their clinical workflows to boost diagnostic efficiency.

Disease Burden Driving Innovation
The growing burden of neurodegenerative and psychological conditions is prompting healthcare innovators to explore new screening modalities. Vocal biomarkers are proving valuable for early detection and disease monitoring, with over 25% of diagnostic research now focused on combining AI algorithms with vocal data to enhance disease recognition and patient management.

Mental Health Monitoring Takes Center Stage
The use of vocal biomarkers in mental health screening is rapidly growing, accounting for over 35% of market deployments. Speech analysis tools provide a non-contact method to assess emotional and psychological states, enabling more frequent and remote assessments that support continuous care models.

Collaborative Growth Environment
The market is also benefiting from strong academic and industry collaboration. Ongoing clinical trials, pilot programs, and startup investments are accelerating product development. More than 20% of digital health innovation funding is currently being directed toward voice-enabled diagnostics, reflecting a broader shift toward personalized, tech-driven healthcare solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Indication
    2. Market Snapshot, By Composition
    3. Market Snapshot, By Type
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Vocal Biomarkers Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing recognition of the interconnectedness between voice and health

        2. Technological advancements in signal processing

        3. Growing demand for remote monitoring

      2. Restraints
        1. Limited standardization

        2. Privacy and security concerns

        3. Regulatory challenges

      3. Opportunities
        1. Expansion of vocal biomarker applications

        2. Integration of voice-based technologies into wearable devices

        3. Collaboration between healthcare providers

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Vocal Biomarkers Market, By Indication, 2021 - 2031 (USD Million)
      1. Psychiatric Disorders

      2. Neurological Disorders

      3. Respiratory Disorders

      4. Others

    2. Vocal Biomarkers Market, By Composition, 2021 - 2031 (USD Million)

      1. Amino Acids

      2. Fats, Carbohydrates

      3. Trace Elements

      4. Vitamins

      5. Minerals

      6. Others

    3. Vocal Biomarkers Market, By Type, 2021 - 2031 (USD Million)

      1. Frequency

      2. Amplitude

      3. Error Rate

      4. Vocal Rise or Fall Time

      5. Phonation Time

      6. Others

    4. Vocal Biomarkers Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics

      2. Research Institutes

      3. Others

    5. Vocal Biomarkers Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. IBM Corporation
      2. Audio Profiling
      3. Cogito Corporation
      4. Sonde Health
      5. Beyond Verbal
      6. Boston Technology Corporation
      7. Microtest Health
  7. Analyst Views
  8. Future Outlook of the Market